Sylwestrowicz T, Sokolowska K
Acta Haematol Pol. 1975 Jan-Mar;6(1):69-76.
Using the biological test on rats the thrombocytopoietic activity (AT) was determined in sera of 13 patients with idiopathic thrombocytopenia (ITP), 5 patients with pancytopenia and bone marrow hypoplasia, 18 with thrombocytopenia developing during proliferative diseases of the haemopoietic system, and 4 patients with erythremia vera. A high mean thrombocytopoietic activity was demonstrated in ITP and this high activity was accounted for by significantly raised AT in acute thrombocytopenia. Increased AT was observed also in myeloproliferative syndromes associated with thrombocytopenia, while in pancytopenia with bone marrow hypoplasia and in erythremia vera AT seemed not increased independently of the stage of the disease. Greater number of cases will be necessary for drawing reliable conclusions.
通过对大鼠进行生物学试验,测定了13例特发性血小板减少症(ITP)患者、5例全血细胞减少症和骨髓发育不全患者、18例造血系统增殖性疾病期间出现血小板减少症的患者以及4例真性红细胞增多症患者血清中的血小板生成活性(AT)。ITP患者表现出较高的平均血小板生成活性,这种高活性是由急性血小板减少症中显著升高的AT所致。在与血小板减少症相关的骨髓增殖综合征中也观察到AT升高,而在骨髓发育不全的全血细胞减少症和真性红细胞增多症中,AT似乎不会独立于疾病阶段而升高。需要更多病例才能得出可靠结论。